Javlin
Join the Javlin Capital Mailing List
Menu 
  • About Us
        • Our History
        • Our Culture
        • The Value
        • The Details
        • The Difference
        • Business Process
        • Stewardship
      • Javlin Capital builds equity for investors and owners of hard-to-liquidate assets. We combine investing acumen with operational expertise to help partners maximize the value of their assets.
  • Verticals
        • Consumer Receivables
        • Education Finance and Student Loans
        • Healthcare Finance
        • Real Estate Assets
        • Litigation Finance
      • We take a creative approach to valuing and investing in a wide range of specialty assets.
  • Team
        • Team
        • Board of Managers
      • We know what it takes to operate successfully in the markets we target. Our clients get the benefit of a partner with hands-on industry experience and operational know-how.
  • Contact Us
  • Careers
  • News/Insights







✎

The painful (and shocking) realities of pain therapies

Free Download

The votes are in and everyone agrees: pain is bad. But what everyone does not agree on is how to treat pain most effectively in a fiscally sensible manner.

As you may know, “acute” pain lasts less than 30 days, “subacute” pain lasts one to six months, and “chronic” pain lasts more than six months. All pain severities warrant different therapy options—typically oral or topical, depending on each patient’s individual needs.

Oral

Oral therapies commonly prescribed for pain management are categorized in three ways:

  1. Nonsteroidal anti-inflammatory drugs (e.g., Advil, Aleve, etc.);
  2. Narcotics (opioids [e.g., Vicodin, OxyContin, etc.]); and
  3. Adjuvants (e.g., antidepressants, local anesthetics, etc.).

Opioids, specifically, have been used for thousands of years, dating back to 3400 B.C. when Sumerians were consuming the opium poppy. Today’s versions can be effective but often cause complications and side effects such as sedation, dizziness, nausea, vomiting, constipation, physical dependence, tolerance, and respiratory depression.1 They’ve also been found to irritate the lining of the esophagus, causing an increase in acid reflux and Gastroesophageal Reflux Disease (GERD). // Download to read more

About Javlin Capital  |  Culture  |  Value  |  Details  |  Difference  

Tags: Analgesics, Compound Topical Creams, Healthcare, Insights, Opioids, Pain Management

Sign Up for Javlin Insights

Business Process

We take a fresh look at how to evaluate and finance the wide range of assets our partners purchase. Javlin serves as an investor for non-performing assets, and as a direct investor in healthcare receivables.

. . . read more


Consumer Receivables

Javlin invests with experienced buyers of secured and unsecured, performing and non-performing consumer loans, including charged-off credit card receivables, installment loans, student loans, auto loans.

. . . read more


Litigation Finance

Javlin addresses the funding requirements of plaintiffs and law firms by methodically evaluating causation, liability, and damages on a case-by-case basis.

. . . read more


Heathcare Finance

Javlin invests in healthcare claims that have an extended payment cycle due to complex adjudication processes or litigation. These claims are typically tied to a workers’ compensation injury or an injury that is a result.

. . . read more


Real Estate Assets

Javlin invests in various asset classes in the distressed mortgage and REO market. Javlin and its operating partners target a wide range of assets that include non-performing 1st lien mortgages, semi-performing and non-performing.

. . . read more


About Javlin

Today, you need more than a source of capital. You need a partner - one whose interests are aligned with yours and who cares as much as you do about driving investment returns. You need a partner who provides objective advice when you need it most. You need a partner who works alongside you every day.

We’ve crafted an approach combining a unique mix of financial resources, creativity and operational expertise to help our partners survive and thrive. In five years, we’ve invested more than $500 million in asset portfolios across a variety of asset classes. We’ve formed successful relationships with dozens of partners across the markets we serve.

Meet Our Team
“Allie”“Education: University of Nebraska - Omaha, B.S.B.A | Experience: BKD LLP, AmeriFirst Finance Company | Organizations I Support: Kiwanis Club of Omaha, Nebraska Humane Society, Girls Incorporated | Favorite Activity: Spending time with family, Nebraska Football, and running - Allie Bruening, CPA " | View Team
© Javlin Capital LLC • All Rights Reserved • Javlin Capital LLC • 1414 Harney Street, Suite 440 • Omaha, NE 68102 • Ph: 402.218.1610
  • Website Terms of Use
  • Online Privacy Policy
  • Equal Employment Opportunity Policy
West Partners Leads Capital Raise for Javlin Capital West Partners $30 Million Facility for Purchasing Non-performing Residential Mortgages in...
Javlin

Javlin

  • Home
  • About Us
    • Business Process
    • The Difference
    • The Value
    • The Details
    • Our Culture
    • Our History
    • Back
  • Verticals
    • Real Estate Assets
    • Litigation Finance
    • Healthcare Finance
    • Education Finance and Student Loans
    • Consumer Receivables
    • Back
  • Team
  • Contact Us
  • Careers
  • News/Insights